As the Single Longest-Running Conference in the Space, Arrowhead Publishers' annual event continues to be the "go to" meeting for pharma executives, academicians, researchers and patient advocacy groups who want to keep abreast of new developments in the field, learn from experts and meet possible collaborators and partners.
Key Subjects Covered at This Event:
Patient Advocacy Efforts
Emphasis on and engagement with patient advocacy groups, who are investing in drug repositioning efforts to an unprecedented degree.
Artificial intelligence and other technologies are quickly reshaping drug discovery and development. This event will showcase how they are reshaping the field of drug repurposing.
The conference will explore how new partnerships between various groups, including government, industry and academia are advancing repurposing.
Regulatory and Legal Guidance
Legal, IP and regulatory guidance will be shared with the audience, including knowlege and insight into the 505(b)(2) regulatory pathway.
Systematic Repositioning and Data Analytics
Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success.
Key Therapeutic Areas for Repurposing
Repurposing is beginning to make its mark in a range of therapeutic areas in need of new therapies. Rare and orphan diseases, tropical diseases and cancer will be discussed in terms of repurposing efforts currently underway.
Industry Early Bird Rate: USD 1395.0,
Academic Early Bird Rate: USD 595.0
Speakers: Pankaj Agarwal, Ph.D., Senior Fellow and Senior Director, GlaxoSmithKline, Heather Stone, MPH, Health Science Policy Analyst, Office of Medical Policy, CDER, US Food and Drug Administration, Aris Persidis, Ph.D., President, Biovista, Tudor Oprea, Ph.D., Prof. of Medicine, Chief, Translational Informatics Div., Dept. of Internal Medicine, University of New Mexico, Dong Liu, Ph.D., Associate Director of Translational Science, AstraZeneca, Dr. Bruce Bloom, Founder, Cures Within Reach, Plus Many More